3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Unknown
1
Sponsor Class
INDUSTRY
1
FED
1
Study Type
Interventional
19
Observational
2
Sponsor
Cancer Type
Plasma cell
2
Sarcoma
1
Conditions
Multiple Myeloma
2
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Surveys and Questionnaires
38
Blood Specimen Collection
24
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Interviews as Topic
10
Observation
9
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mastectomy, Segmental
5
Biopsy
5
ribociclib
4
palbociclib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Mental Status and Dementia Tests
4
Magnetic Resonance Imaging
4
Ipilimumab
4
Immune Checkpoint Inhibitors
4
High-Throughput Nucleotide Sequencing
4
Echocardiography
4
Bevacizumab
4
lorlatinib
3
atezolizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
selinexor
×
Clear all
NCT05954780
2026-01-14
SEATTLE
iOMEDICO AG
Active not recruiting
75 enrolled
NCT06452446
2025-02-10
Selinexor
Durham VA Medical Center
Active not recruiting
20 enrolled